Last edition
News about "Azurity Pharmaceuticals"
Lupin Launches Azilsartan Medoxomil Tablets in US
Lupin has launched Azilsartan Medoxomil Tablets in the US, a bioequivalent generic version of Edarbi, indicated for the treatment of hypertension in adults.
Azurity Pharmaceuticals | 17/06/2026 | By News Bureau
Lupin Receives US FDA Approval for Sodium Sulfate, Magnesium Sulfate and Potassium Chloride Tablets
Lupin has received US FDA approval for its Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, a bioequivalent to Reference Listed Drug (RLD) Sutab Tablets of Azurity Pharmaceuticals.
Azurity Pharmaceuticals | 02/06/2026 | By News Bureau
Azurity Pharmaceuticals Announces Acquisition of Covis Pharma
By combining expertise and resources, Azurity strengthens its ability to deliver medicines to overlooked patients on a global scale.
Azurity Pharmaceuticals | 15/03/2025 | By Aishwarya | 537
Azurity Pharmaceuticals Receives FDA Approval for Myhibbin
Mycophenolate mofetil, an antimetabolite immunosuppressant crucial in safeguarding transplanted organs from rejection by the body's immune system, is a vital medication for organ transplant recipients.
Azurity Pharmaceuticals | 07/05/2024 | By Abha | 741
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy